ATE348116T1 - Kristalline mischungen aus teilmethylestern des beta-cyclodextrins und verwandten verbindungen - Google Patents

Kristalline mischungen aus teilmethylestern des beta-cyclodextrins und verwandten verbindungen

Info

Publication number
ATE348116T1
ATE348116T1 AT00991953T AT00991953T ATE348116T1 AT E348116 T1 ATE348116 T1 AT E348116T1 AT 00991953 T AT00991953 T AT 00991953T AT 00991953 T AT00991953 T AT 00991953T AT E348116 T1 ATE348116 T1 AT E348116T1
Authority
AT
Austria
Prior art keywords
cyclodextrin
beta
mixtures
methyl esters
related compounds
Prior art date
Application number
AT00991953T
Other languages
English (en)
Inventor
Freres Roquette
Original Assignee
Freres Roquette
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Freres Roquette filed Critical Freres Roquette
Application granted granted Critical
Publication of ATE348116T1 publication Critical patent/ATE348116T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/16Cyclodextrin; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Nanotechnology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Materials Engineering (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT00991953T 1999-11-12 2000-11-09 Kristalline mischungen aus teilmethylestern des beta-cyclodextrins und verwandten verbindungen ATE348116T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16494999P 1999-11-12 1999-11-12

Publications (1)

Publication Number Publication Date
ATE348116T1 true ATE348116T1 (de) 2007-01-15

Family

ID=22596786

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00991953T ATE348116T1 (de) 1999-11-12 2000-11-09 Kristalline mischungen aus teilmethylestern des beta-cyclodextrins und verwandten verbindungen

Country Status (10)

Country Link
US (1) US6602860B1 (de)
EP (1) EP1272531B8 (de)
JP (1) JP2003514925A (de)
CN (1) CN1303107C (de)
AT (1) ATE348116T1 (de)
AU (1) AU3643301A (de)
CA (1) CA2391008C (de)
DE (1) DE60032388T2 (de)
MX (1) MXPA02004743A (de)
WO (1) WO2001036490A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1462512B1 (de) * 2003-03-24 2007-08-01 The Procter & Gamble Company Zusammensetzungen enthaltend Cyclodextrinkomplexe und mindestens ein Waschmitteladditiv
PL2434886T3 (pl) 2009-05-29 2020-05-18 Cydex Pharmaceuticals, Inc. Kompozycje do wstrzykiwania melfalanu zawierające pochodną cyklodekstryny i sposoby ich wytwarzania i stosowania
US11020363B2 (en) 2009-05-29 2021-06-01 Cydex Pharmaceuticals, Inc. Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same
FR2953139B1 (fr) * 2009-11-27 2012-04-13 Servier Lab Composition pharmaceutique comprenant un sel de strontium, de la vitamine d et une cyclodextrine
FR3014694B1 (fr) 2013-12-13 2016-11-11 Roquette Freres Compositions a base de methyl-cyclodextrines pour le traitement et/ou la prevention de maladies par augmentation du taux de cholesterol-hdl
FR3042501B1 (fr) 2015-10-16 2017-11-03 Roquette Freres Nouvelles cyclodextrines methylees et leurs procedes de preparation
WO2021180742A1 (en) 2020-03-09 2021-09-16 Virtexx Methyl-cyclodextrin for use in treating enveloped virus infections such as cov-2
FR3115682B1 (fr) 2020-11-05 2023-02-24 Roquette Freres Compositions à base de méthyl-cyclodextrines pour le traitement et/ou la prévention de la stéatose hépatique
CN113529418B (zh) * 2021-06-29 2023-06-09 安徽三宝棉纺针织投资有限公司 利用有机棉制备抗菌防螨襁褓用品的工艺

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0651725B2 (ja) * 1985-02-28 1994-07-06 メルシャン株式会社 部分メチル化シクロデキストリン及びその製造方法
US4933948A (en) * 1989-05-30 1990-06-12 Eastman Kodak Company Dye laser solutions
US5472954A (en) * 1992-07-14 1995-12-05 Cyclops H.F. Cyclodextrin complexation
HU218280B (en) * 1994-04-26 2000-07-28 Cyclodextrin inclusion complexes containing sin-1a which are stable intheir solid state, process for their preparation and pharmaceutical compositions containing the comlexes
DE19505263A1 (de) * 1995-02-16 1996-08-22 Consortium Elektrochem Ind Verfahren zur Reinigung von wasserlöslichen Cyclodextrinderivaten

Also Published As

Publication number Publication date
US6602860B1 (en) 2003-08-05
EP1272531A4 (de) 2003-03-19
CA2391008A1 (en) 2001-05-25
CN1620469A (zh) 2005-05-25
MXPA02004743A (es) 2003-10-14
DE60032388D1 (de) 2007-01-25
EP1272531B1 (de) 2006-12-13
EP1272531B8 (de) 2007-02-14
JP2003514925A (ja) 2003-04-22
DE60032388T2 (de) 2008-01-10
AU3643301A (en) 2001-05-30
EP1272531A2 (de) 2003-01-08
CN1303107C (zh) 2007-03-07
WO2001036490A3 (en) 2001-11-08
WO2001036490A2 (en) 2001-05-25
CA2391008C (en) 2009-12-22

Similar Documents

Publication Publication Date Title
ATE348116T1 (de) Kristalline mischungen aus teilmethylestern des beta-cyclodextrins und verwandten verbindungen
TWI255828B (en) Highly nucleated thermoplastic articles
WO2008104960A8 (en) Personal care product comprising cyclodextrin as fragrance- complexing material
WO2008104954A3 (en) Personal care product comprising cyclodextrin as fragrance-complexing material
DE60023289D1 (de) Cyclodextrin zur geruchskontrolle in deodorant-zusammensetzungen
JO2293B1 (en) Derivatives of 3-indoleil 4-phenyl-1H-birol-5.2 -Dayon as inhibitors of glycogen synthacinase-3b
MXPA05014082A (es) Acidos biariloximetilarenocarboxilicos.
WO2008009831A3 (fr) Derives de cyclodextrines amphiphiles
DK1041072T3 (da) Dioxocyclopentylhydroxamsyrer
HK1096241A2 (en) Skin lightening compositions
HUP0204157A3 (en) 1,3-dihydro-2h-indol-2-one derivatives, process for preparation of the compounds and pharmaceutical compositions containing the same
WO2006100082A3 (de) Substituierte oxindol-derivate, diese enthaltende arzneimittel und deren verwendung
WO2001091738A3 (en) Naaladase inhibitors for treating amyotrophic lateral sclerosis
MXPA02009270A (es) Aditivo hidrofilico.
BG105731A (en) 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
WO2003063824A3 (en) Pharmaceutical composition
BR0102430A (pt) Precursores de fragrância
HUP0202433A3 (en) Substituted pyrrolidin-2,3,4-trion-3-oxime derivatives useful as nmda-receptor antagonists, process for producing them and pharmaceutical compositions containing them
WO2005007635A8 (en) Combretastatin derivatives with cytotoxic action
EE200200326A (et) Asendatud homopiperidüülbensimidasooli analoog, meetod selle valmistamiseks ning seda sisaldav farmatseutiline kompositsioon
HUP0100974A2 (hu) Integrált additív készítmény, eljárás előállítására és alkalmazására
ATE528990T1 (de) Desinfektions- und entkeimungsmittel
WO2007059507A3 (en) Compositions comprising lipoxygenase inhibitors and cyclodextrin
WO2005053660A3 (en) Pharmaceutical compositions comprising danazol
WO2007069217A3 (en) Absorbent products having complementary fragrances and a package for storing absorbent products

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties